Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
Clinical trial NCT03467516 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03467516
- Sponsor
- Udai Kammula
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2027-07-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.